• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

AXA

Notes

No. Proposition For Against Abstain
1

Approval of the parent Company financial statements for the fiscal year ended December 31,?2025

2

Approval of the consolidated financial statements for the fiscal year ended December 31,?2025

3

Income appropriation for the fiscal year ended December 31,?2025 and setting of a dividend of €2,32 per share

4

Approval of the information referred to in Article L.22-10-9, I of the French Commercial Code (Code de commerce) relating to the compensation of corporate officers (mandataires sociaux)

5

Approval of the components of compensation paid during, or granted in respect of, the fiscal year ended December 31,?2025 to Antoine?Gosset-Grainville, Chairman of the Board of Directors

6

Approval of the components of compensation paid during, or granted in respect of, the fiscal year ended December 31,?2025 to Thomas?Buberl, Chief Executive Officer

7

Approval of the compensation policy of the Chairman of the Board of Directors

8

Approval of the compensation policy of the Chief Executive Officer

9

Approval of the compensation policy of the directors

10

Statutory Auditors’ special report on agreements referred to in Article L.225-38 of the French Commercial Code

11

Renewal of the mandate of Thomas Buberl as director for a four-year term

12

Renewal of the mandate of Ewout Steenbergen as director for a four-year term

13

Renewal of the mandate of Rachel Picard as director for a three-year term

14

Renewal of the mandate of Grald Harlin as director for a two-year term

15

Appointment of Philomena Colatrella as director for a three-year term

16

Authorization granted to the Board of Directors to operate on the shares of the Company

17

Authorization granted to the Board of Directors to reduce the share capital of the Company through cancellation of treasury shares

18

Delegation of power granted to the Board of Directors to increase the share capital by issuing shares or securities giving a right to the Company’s shares, reserved for employees enrolled in an employer-sponsored Company savings plan, without preferential subscription rights of the shareholders

19

Delegation of power granted to the Board of Directors to increase the share capital by issuing shares, without preferential subscription rights of the shareholders, in favor of a specific category of beneficiaries

20

Amendments of Article 10 C) of the Bylaws relating to the appointment of the employee shareholder representative to the Board of Directors

21

Amendment of Article 23 of the Bylaws relating to Shareholders’ Meetings to comply with the new regulation